Challenges of combination therapy with immune checkpoint inhibitors for hepatocellular carcinoma
National Taiwan University · National Taiwan University Hospital · +3 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
564
total citations
- FWCI
- 32.72
- Percentile
- 100%
- References
- 159
Citations per year
Authors
5- ACAnn‐Lii ChengCorresponding
National Taiwan University, National Taiwan University Hospital
- CHChiun HsuCorresponding
National Taiwan University, National Taiwan University Hospital
- SLStephen L. Chan
Chinese University of Hong Kong
- SCSu-Pin Choo
National Cancer Centre Singapore
- MKMasatoshi Kudo
Kindai University
Topics & keywords
Topics
Keywords
- Medicine
- Immunotherapy
- Oncology
- Combination therapy
- Hepatocellular carcinoma
- Clinical trial
- Internal medicine
- Adverse effect
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.